Search for Clinical Trial Results
Hemosiderosis - 27 Studies Found
Status | Study |
Withdrawn |
Study Name: Treatment of Iron Overload Requiring Chelation Therapy Condition:
|
Enrolling by invitation |
Study Name: A Case Control Study to Evaluate the Cognitive and Brain Function of β-thalassemia Patients. Condition:
Date: 2013-08-07 |
Enrolling by invitation |
Study Name: PHOX2B Mutation-Confirmed Congenital Central Hypoventilation Syndrome in A Chinese Family: Presentations From Newborn to Adulthood Condition: Central Alveolar Hypoventilation Syndrome Date: 2008-04-01 Interventions: Device: CPAP CPAP treatment for patients with congenital central hypoventilation syndrome |
Completed |
Study Name: Evaluation of the Safety, Tolerability, Pharmacokinetics (PK) and Effects on Liver Iron Concentration of ICL670 Relative to Deferoxamine(DFO). Condition: Sickle Cell Disease Date: 2010-03-15 Interventions: Drug: ICL670 Daily doses of ICL670 were taken orally 30 minutes before breakfast. The doses range from 5 |
Completed |
Study Name: A Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe Toxicity Condition: Transfusional Iron Overload Date: 2010-01-05 Interventions: Drug: ICL670 |
Not yet recruiting |
Study Name: Efficacy of Bone Marrow Mesenchymal Stem Cell in Pulmonary Hemosiderosis Condition: Idiopathic Pulmonary Hemosiderosis Date: 2016-12-03 Interventions: Biological: Bone marrow mesenchymal stem cells in treatment of Idiopathic pulmonary hemosiderosis |
Not yet recruiting |
Study Name: PHOX2B Mutation-Confirmed Congenital Central Hypoventilation Syndrome in A Chinese Family: Presentations From Newborn to Adulthood Condition: Central Alveolar Hypoventilation Syndrome Date: 2008-04-01 Interventions: Device: CPAP CPAP treatment for patients with congenital central hypoventilation syndrome |